Researchers studied the perspectives of patients with rheumatoid arthritis and RA providers to understand the barriers and facilitators regarding coverage of the influenza and pneumococcal vaccines.
Experts in the field of obstetrics and epidemiology share how they are helping their patients make informed clinical decisions about vaccination for SARS-CoV-2.
Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.
Researchers evaluated response to the COVID-19 vaccine in patients undergoing hemodialysis in light of the frequency of vaccine hyporesponsiveness in immunocompromised patients.
Clinicians report the cutaneous reactions experienced by healthcare workers who received the Pfizer COVID-19 vaccine.
Patients with immune-mediated inflammatory diseases (IMIDs) receiving background methotrexate have worse humoral and cellular immunogenicity to mRNA COVID-19 vaccines.
The authors present seven cases of acute myocarditis or myopericarditis in healthy male adolescents within four days of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccination.
Plunging vaccination rates are imperiling President Joe Biden’s goal of getting COVID-19 shots into the arms of at least 70% of American adults by July 4.
There is a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19.
The BNT162b2 COVID-19 vaccine is safe and effective for adolescents aged 12 to 15 years.
